INTRODUCTION: For 30 years synapse loss has been referred to as the major pathological correlate of cognitive impairment in Alzheimer's disease (AD). However, this statement is based on remarkably few patients studied by autopsy or biopsy. With the recent advent of synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) imaging, we have begun to evaluate the consequences of synaptic alterations in vivo. METHODS: We examined the relationship between synaptic density measured by [11 C]UCB-J PET and neuropsychological test performance in 45 participants with early AD. RESULTS: Global synaptic density showed a significant positive association with global cognition and performance on five individual cognitive domains in participants with early AD. Synaptic density was a stronger predictor of cognitive performance than gray matter volume. CONCLUSION: These results confirm neuropathologic studies demonstrating a significant association between synaptic density and cognitive performance, and suggest that this correlation extends to the early stages of AD.
INTRODUCTION: For 30 years synapse loss has been referred to as the major pathological correlate of cognitive impairment in Alzheimer's disease (AD). However, this statement is based on remarkably few patients studied by autopsy or biopsy. With the recent advent of synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) imaging, we have begun to evaluate the consequences of synaptic alterations in vivo. METHODS: We examined the relationship between synaptic density measured by [11 C]UCB-J PET and neuropsychological test performance in 45 participants with early AD. RESULTS: Global synaptic density showed a significant positive association with global cognition and performance on five individual cognitive domains in participants with early AD. Synaptic density was a stronger predictor of cognitive performance than gray matter volume. CONCLUSION: These results confirm neuropathologic studies demonstrating a significant association between synaptic density and cognitive performance, and suggest that this correlation extends to the early stages of AD.
Authors: Hugo W A M de Jong; Floris H P van Velden; Reina W Kloet; Fred L Buijs; Ronald Boellaard; Adriaan A Lammertsma Journal: Phys Med Biol Date: 2007-02-14 Impact factor: 3.609
Authors: R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman Journal: Ann Neurol Date: 1991-10 Impact factor: 10.422
Authors: Kjell Erlandsson; Irène Buvat; P Hendrik Pretorius; Benjamin A Thomas; Brian F Hutton Journal: Phys Med Biol Date: 2012-10-16 Impact factor: 3.609
Authors: Adam P Mecca; Nicole M Barcelos; Shuo Wang; Anna Brück; Nabeel Nabulsi; Beata Planeta-Wilson; Jennifer Nadelmann; Amanda L Benincasa; Jim Ropchan; Yiyun Huang; Joel Gelernter; Peter H Van Ness; Richard E Carson; Christopher H van Dyck Journal: Neurobiol Aging Date: 2017-10-06 Impact factor: 4.673
Authors: Ryan S O'Dell; Adam P Mecca; Ming-Kai Chen; Mika Naganawa; Takuya Toyonaga; Yihuan Lu; Tyler A Godek; Joanna E Harris; Hugh H Bartlett; Emmie R Banks; Victoria L Kominek; Wenzhen Zhao; Nabeel B Nabulsi; Jim Ropchan; Yunpeng Ye; Brent C Vander Wyk; Yiyun Huang; Amy F T Arnsten; Richard E Carson; Christopher H van Dyck Journal: Alzheimers Res Ther Date: 2021-01-05 Impact factor: 6.982
Authors: Emma M Coomans; Deborah N Schoonhoven; Hayel Tuncel; Sander C J Verfaillie; Emma E Wolters; Ronald Boellaard; Rik Ossenkoppele; Anouk den Braber; Wiep Scheper; Patrick Schober; Steven P Sweeney; J Michael Ryan; Robert C Schuit; Albert D Windhorst; Frederik Barkhof; Philip Scheltens; Sandeep S V Golla; Arjan Hillebrand; Alida A Gouw; Bart N M van Berckel Journal: Alzheimers Res Ther Date: 2021-02-05 Impact factor: 6.982